Patents by Inventor Christian Vitzling

Christian Vitzling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • New Oral Formulation
    Publication number: 20120071537
    Abstract: The present invention relates to a pharmaceutical composition, in particular to a composition for administering active agents which are poorly soluble in aqueous media, and/or which are acid sensitive.
    Type: Application
    Filed: November 23, 2011
    Publication date: March 22, 2012
    Inventors: Karel De Bruijn, Günter Engel, Hans-Jürgen Pfannkuche, Michael Thewissen, Christian Vitzling, Othmar Züger
  • 5-HT4 partial agonist pharmaceutical compositions
    Publication number: 20090104263
    Abstract: A solid pharmaceutical composition for oral administration comprising tegaserod in base or salt form in an amount of up to 10% by weight a bulking agent in an amount of 70 to 90% by weight a disintegrant in an amount of less than 15% by weight a glidant and a lubricant,
    Type: Application
    Filed: October 7, 2008
    Publication date: April 23, 2009
    Inventors: Jerome Aubert, Christian Vitzling
  • New Oral Formulation
    Publication number: 20080075773
    Abstract: The present invention relates to a pharmaceutical composition, in particular to a composition for administering active agents which are poorly soluble in aqueous media, and/or which are acid sensitive.
    Type: Application
    Filed: November 29, 2007
    Publication date: March 27, 2008
    Inventors: Karel De Bruijn, Gunter Engel, Hans-Jurgen Pfannkuche, Michael Thewissen, Christian Vitzling, Othmar Zuger
  • Stable modifications of tegaserod hydrogen maleate
    Publication number: 20070112056
    Abstract: The present invention relates to crystalline forms of tegaserod hydrogen maleate, their use, in pharmaceutical compositions useful in the treatment of irritable bowel syndrome, gastro-esophageal reflux diseases, functional dyspepsia, chronic constipation or diarrhea, and their production.
    Type: Application
    Filed: July 23, 2004
    Publication date: May 17, 2007
    Inventors: Sabine Pfeffer, Christian Vitzling
  • Oral suspension of tegaserod
    Publication number: 20070043102
    Abstract: This invention relates to an oral suspension of tegaserod or pharmaceutically acceptable salts thereof. In particular, it relates to an oral suspension comprising a power comprising an effective amount otegaserod or a pharmaceutically acceptable salt thereof in a beverage, e.g. apple juice.
    Type: Application
    Filed: March 30, 2004
    Publication date: February 22, 2007
    Inventors: Marie-Noelle Bizot, Mark Iwicki, Christian Vitzling
  • 5-Ht4partial agonist pharmaceutical compositions
    Publication number: 20050106236
    Abstract: A solid pharmaceutical composition for oral administration comprising tegaserod in base or salt form in an amount of up to 10% by weight a bulking agent in an amount of 70 to 90% by weight a disintegrant in an amount of less than 15% by weight a glidant and a lubricant.
    Type: Application
    Filed: December 20, 2002
    Publication date: May 19, 2005
    Inventors: Jerome Aubert, Christian Vitzling
  • Oral formulation
    Publication number: 20030236183
    Abstract: The present invention relates to a pharmaceutical composition, in particular to a composition for administering active agents which are poorly soluble in aqueous media, and/or which are acid sensitive.
    Type: Application
    Filed: July 15, 2003
    Publication date: December 25, 2003
    Inventors: Karel De Bruijn, Gunter Engel, Hans-Jurgen Pfannkuche, Michael Thewissen, Christian Vitzling, Othmar Zuger